Allergy to bufexamac.
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy; D003877:Dermatitis, Contact / Q000209:etiology*; D004487:Edema / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D005260:Female; D006801:Humans; D006877:Hydroxamic Acids / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010648:Phenylacetates / Q000009:adverse effects / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D006877:Hydroxamic Acids; D010648:Phenylacetates